MedPath

Effect of Nicardipine on Renal Function in Deliberate Hypotension

Phase 4
Completed
Conditions
Spinal Stenosis
Interventions
Registration Number
NCT02271191
Lead Sponsor
Yonsei University
Brief Summary

The aim of this study was to demonstrate the effect of nicardipine on renal function with creatinine clearance, serum cystatin C, urine output and fractional excretion of sodium during deliberate hypotension for spine surgery.

Detailed Description

To induce deliberate hypotension, pharmacological agents such as inhalation anesthetics, calcium channel blockers, beta-adrenergic blockers have been used alone or in combination. Nicardipine, classed as a calcium channel blocker, has a peripheral vasodilator effect via relaxation of smooth muscle fiber and sympathetic nerve inhibition. Nicardipine expands the renal artery and increases glomerular filtration rate. Previous studies reported the renal protective effect of nicardipine in cardiac surgery with cardiopulmonary bypass and robot-assisted laparoscopic surgery.

The aim of this study was to demonstrate the effect of nicardipine on renal function with creatinine clearance , serum cystatin C, urine output and fractional excretion of sodium during deliberate hypotension for spine surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Patients undergoing anterior or posterior spine interbody fusion
Exclusion Criteria
  • Patients with American Society of Anesthesiologists physical status III or IV
  • Liver dysfunction with aspartate transaminase/alanine transaminase greater than 60/60 IU/L
  • Cerebrovascular disease
  • Anemia of less than hematocrit 24%
  • Diabetes mellitus
  • Severe malnutrition
  • those diuretics or antihypertensive drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nicardipine and RemifentanilNicardipineintravenous nicardipine and remifentanil during deliberate hypotension
RemifentanilNicardipineintravenous remifentanil during deliberate hypotension
Primary Outcome Measures
NameTimeMethod
urine outputafter deliberate hypotension, and POD1
creatinine clearanceafter deliberate hypotension, and POD1
serum cystatin Cbefore deliberate hypotension, after deliberate hypotension, and POD1
fractional excretion of sodiumbefore deliberate hypotension, after deliberate hypotension, and POD1
Secondary Outcome Measures
NameTimeMethod
Risk, injury, failure, loss, and end stage renal disease (RIFLE) criteriabefore deliberate hypotension, after deliberate hypotension, and POD1
© Copyright 2025. All Rights Reserved by MedPath